In this issue:
- Augmented enteral protein during critical illness
- Low-dose methotrexate for inflammatory knee OA
- Optimal DOAC timing after ischaemic stroke or AF
- Clinical spectrum and incidence of severe acute group A streptococcal disease
- FMT vs. vancomycin for primary C. difficile infection
- Impact of antihypertensive drug class on CV outcomes
- Effects of different opioids for noncancer pain on severe constipation
- Prohaemostatic agents for factor Xa inhibitor associated intracranial haemorrhage
- Concentrated albumin for undifferentiated sepsis in the ED
- Early invasive vs. conservative strategy for older ACS patients
Please login below to download this issue (PDF)